Browse
Submit Data
Databases
API
Help

Dataset Information

15 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MiRNA expression profiling in early stage breast cancer

ABSTRACT: MiRNA profiling from whole blood (EDTA) was used to identify a miRNA profile applicable for early stage breast cancer detection In the study presented here, a consecutively collected, well-defined cohort of 48 patients with early stage breast cancer (invasive ductal carcinoma) at diagnosis was compared with a cohort of 57 healthy individuals for known homo sapiens miRNAs (mirbase 15).

ORGANISM(S): Homo sapiens

SUBMITTER: Schrauder MG

PROVIDER: S-ECPF-GEOD-31309 | biostudies-other | 2012

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Similar Datasets

miRNA expression profiling in early stage breast cancer

Project description:MiRNA profiling from whole blood (EDTA) was used to identify a miRNA profile applicable for early stage breast cancer detection

2012-02-02 | GSE31309 | GEO

miRNA profiling of late stage metastatic Her2+ breast cancer

Project description: Not available

| S-ECPF-GEOD-20066 | biostudies-other

Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer.

Project description: Not available

| S-EPMC5455310 | biostudies-literature

miRNA expression profiling in early stage breast cancer

Project description:MiRNA profiling from whole blood (EDTA) was used to identify a miRNA profile applicable for early stage breast cancer detection In the study presented here, a consecutively collected, well-defined cohort of 48 patients with early stage breast cancer (invasive ductal carcinoma) at diagnosis was compared with a cohort of 57 healthy individuals for known homo sapiens miRNAs (mirbase 15).

2012-02-02 | E-GEOD-31309 | biostudies-arrayexpress

miRNA transcriptome profiling in early-stage luminal breast cancer

Project description:Oxysterols, oxidized derivatives of cholesterol, act in breast cancer (BC) as selective estrogen receptor modulators and affect cholesterol homeostasis, drug transport, nuclear and cell receptors, and other signaling proteins. Using overlapping data from patients with early-stage estrogen receptor-positive BC—high-coverage targeted DNA sequencing (99 patients, 113 genes), mRNA sequencing (67 patients), and full miRNome by microarrays (123 patients)—we describe complex mRNA-miRNA and miRNA-miRNA interaction (correlation) networks, with validation in two carefully curated public datasets (n=538 in total) and 11 databases. The ESR1-CH25H-INSIG1-ABCA9 axis was the most prominent, being interconnected through hsa-miR-125b-5p, but also hsa-miR-99a-5p, hsa-miR-100-5p, hsa miR 143 3p, hsa-199b-5p, hsa-miR-376a-3p, and hsa-miR-376c-3p. Mutations in SC5D, CYP46A1, and its functionally linked gene set were associated with multiple differentially expressed genes. STARD5 was upregulated in patients with positive lymph node status. High expression of miR-19b-3p was weakly associated with poor survival in multiple datasets. This is the first detailed dedicated study of interactions between DNA variation and mRNA expression of oxysterol-related genes, the miRNA transcriptome, and clinical factors in BC.

2023-08-02 | GSE225292 | GEO

Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France.

Project description: Not available

| S-EPMC4472722 | biostudies-literature

miRNA profiling of breast cancer patients

Project description: Not available

| S-ECPF-GEOD-39543 | biostudies-other

miRNA expression profiling in hereditary breast tumors

Project description: Not available

| S-ECPF-GEOD-44899 | biostudies-other

miRNA expression profiling in early-stage epithelial ovarian cancer

Project description:Early-stage epithelial ovarian cancer (eEOC) patients have a generally favorable prognosis but heterogeneous behavior at recurrence. Accurate prediction of the risk of relapse is still a major concern, essentially to avoid overtreatment. We have identified a robust miRNA-based signature named MiROvaR able to predict early disease recurrence in case materials of mostly advanced-stage EOC patients. We challenged MiROvaR in the eEOC sub-setting (stage IA-IIB) and it proved to accurately classify eEOC patients according to their risk of relapse.

2022-12-21 | GSE169314 | GEO

Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype.

Project description: Not available

| S-EPMC2939785 | biostudies-literature